GMF-β/γ Antibodies

Santa Cruz Biotechnology features a diverse variety of GMF-β/γ monoclonal antibodies for research focused on understanding neuronal signaling and immune responses. GMF-β/γ monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GMF-β and GMF-γ play essential roles in regulating neuronal signaling and immune responses. GMF-β and GMF-γ actively modulate GTPase activity, which influences cell growth, differentiation, and motility. Research has shown that GMF-β and GMF-γ significantly impact the development of neurodegenerative diseases and immune system disorders. Scientists worldwide rely on GMF-β/γ monoclonal antibodies to advance their understanding of cellular mechanisms and pathways. Ongoing studies with GMF-β/γ monoclonal antibodies continue to reveal new insights into neurological and immunological conditions. Research utilizing GMF-β/γ monoclonal antibodies from Santa Cruz Biotechnology contributes valuable knowledge to advance scientific understanding of human health and disease.